In an 86-year-old woman with anemia (hemoglobin 9.7 g/dL, hematocrit 30.4 %), low red blood cell count, low MCHC, lymphopenia, normal blood urea nitrogen (BUN), low albumin/globulin (A/G) ratio, and normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT), what is the most likely diagnosis and appropriate treatment?

Diagnosis and Treatment of Anemia in an 86-Year-Old Woman

This patient has normocytic anemia (MCHC 31.9 is normal) with a low albumin/globulin ratio suggesting chronic disease, and the most likely diagnosis is anemia of chronic disease/inflammation, though iron deficiency must be ruled out with ferritin testing before proceeding with treatment.

Diagnostic Assessment

Anemia Classification

• The hemoglobin of 9.7 g/dL meets WHO criteria for anemia in women (Hb <12 g/dL), representing moderate anemia 1, 2.
• The MCHC of 31.9 g/dL is within normal range (32-36 g/dL), indicating normocytic rather than hypochromic anemia 1.
• In elderly patients, anemia is typically multifactorial, with approximately one-third due to nutritional deficiency, one-third from chronic inflammation or chronic kidney disease, and one-third unexplained 2, 3.

Key Laboratory Findings Analysis

• Low A/G ratio (0.8): This suggests either hypoalbuminemia or hyperglobulinemia, both markers of chronic inflammation or chronic disease 4.
• Lymphopenia (19.8%): This supports an underlying chronic inflammatory or infectious process 4.
• Normal liver enzymes (AST 10, ALT 11): Rules out significant hepatic dysfunction as a cause.
• Normal BUN (19): Makes severe chronic kidney disease less likely, though mild renal insufficiency cannot be excluded without creatinine and GFR 4.

Essential Next Steps for Diagnosis

Mandatory Laboratory Tests

You must obtain the following before determining treatment 1, 5:

• Serum ferritin: This is the most specific test for iron deficiency in the absence of inflammation 1.

  • Ferritin <15 μg/L confirms iron deficiency (specificity 0.99) 1.
  • Ferritin <45 μg/L suggests iron deficiency even with inflammation 1, 5.
  • Ferritin >150 μg/L excludes iron deficiency even with inflammation 1.

• Complete iron panel: Including serum iron, total iron-binding capacity (TIBC), and transferrin saturation 1, 5.

• Creatinine and estimated GFR: To assess for chronic kidney disease as a contributor 4.

• Vitamin B12 and folate levels: Nutritional deficiencies account for one-third of anemia in elderly patients 2, 3.

• C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR): To assess for chronic inflammation 4.

Additional Considerations

• Mean corpuscular volume (MCV): Should be reviewed (not provided in labs) to confirm normocytic pattern 1.
• Reticulocyte count: To assess bone marrow response 4.

Most Likely Diagnoses (Pending Ferritin)

Primary Differential

1. Anemia of chronic disease/inflammation (most likely given low A/G ratio and lymphopenia) 4, 6:

   • Characterized by normocytic anemia with elevated ferritin (typically 30-200 μg/L) but low transferrin saturation 4.
   • Associated with chronic inflammatory state common in elderly 7, 6.

2. Iron deficiency anemia (must be excluded) 1, 5:

   • Can present as normocytic in early stages before becoming microcytic 1.
   • Requires gastrointestinal evaluation if confirmed, as GI blood loss is the most common cause in elderly non-menstruating women 1, 5.

3. Combined iron deficiency and chronic disease 4:

   • Common in elderly patients with chronic conditions 3, 4.

4. Unexplained anemia 2, 7:

   • Accounts for one-third of anemia in elderly, possibly due to bone marrow resistance to erythropoietin and subclinical inflammation 7.

Treatment Algorithm

If Ferritin <45 μg/L (Iron Deficiency Confirmed)

Initiate oral iron supplementation 1, 5:

• Ferrous sulfate 325 mg (65 mg elemental iron) once daily, preferably on an empty stomach 5.
• Lower doses may improve tolerability with similar efficacy 5.
• Continue for 3-6 months after hemoglobin normalization to replete stores 1.

Gastrointestinal evaluation is mandatory 1, 5:

• Upper endoscopy and colonoscopy to identify bleeding source 1.
• Consider celiac disease testing (tissue transglutaminase antibodies) 5.
• Evaluate for Helicobacter pylori infection 5.

Consider intravenous iron if 5:

• Intolerance to oral iron (nausea, constipation, abdominal pain).
• Inadequate response after 4-6 weeks of oral therapy.
• Ongoing blood loss.
• Malabsorption conditions.

If Ferritin 45-150 μg/L with Low Transferrin Saturation

This suggests combined iron deficiency and chronic disease 4:

• Trial of oral iron supplementation is reasonable 5.
• Treat underlying chronic conditions aggressively 4.
• Monitor response at 4-6 weeks; if inadequate, consider IV iron 5.

If Ferritin >150 μg/L (Anemia of Chronic Disease)

Focus on treating underlying condition 4:

• Investigate and manage chronic inflammatory conditions.
• Optimize nutrition with dietary counseling 5.
• Ensure adequate vitamin B12 and folate intake 2, 4.

Erythropoiesis-stimulating agents 4, 6:

• Reserved for specific indications (chronic kidney disease, cancer-related anemia).
• Not routinely recommended for unexplained anemia in elderly 2.

Critical Pitfalls to Avoid

• Do not assume normocytic anemia excludes iron deficiency: Early iron deficiency can be normocytic before progressing to microcytic 1.
• Do not rely on MCHC alone: Ferritin is essential for diagnosis 1, 5.
• Do not skip GI evaluation if iron deficient: Even mild iron deficiency in elderly non-menstruating women warrants investigation for occult GI bleeding 1, 5.
• Do not ignore the low A/G ratio: This suggests chronic disease that requires identification and treatment 4.
• Do not accept "anemia of aging": Even mild anemia in elderly is associated with increased mortality, cognitive dysfunction, falls, and reduced quality of life 2, 6.

Monitoring and Follow-Up

• Recheck complete blood count and iron studies in 4-6 weeks after initiating treatment 1, 5.
• Expected response: Hemoglobin should increase by 1-2 g/dL within 3-4 weeks if treatment is effective 1.
• If no response: Consider IV iron, evaluate for ongoing blood loss, or reassess diagnosis 5.